FDA.reportPublic FDA data

Vacation Super

Manufacturer
Vacation Inc.
Effective date
2024-03-12
Label type
HUMAN OTC DRUG LABEL
Version
1
Source
full-release
Hydrated at
2026-06-01 00:09:41

Label at a glance#

ProductVacation Super
Active ingredientOCTOCRYLENE, AVOBENZONE, HOMOSALATE, OCTISALATE
Label structure7 sections

Indications and uses

Helps prevent sunburn If used as directed with other sun protection measures (see Directions), decreases the risk of skin cancer and early skin aging caused by the sun

Label contents#

Full prescribing information#

DOSAGE & ADMINISTRATION SECTION

Apply liberally 15 minutes before sun exposure

Reapply at least every 2 hours

WARNINGS SECTION

For external use only

Do not use on damaged or broken skin

When using this product keep out of eyes

Rinse with water to remove

Stop use and ask a doctor if rash occurs

Inactives

INACTIVE INGREDIENT SECTION

Aloe Barbadensis Leaf Juice

Butyloctyl Salicylate

Calcium Sodium Phosphosilicate

Camellia Sinensis Leaf Extract

Caprylic/Capric Triglyceride

Ceramide NG

Ceramide NP

Cetyl Esters

Chlorella Vulgaris Extract

Cocos Nucifera (Coconut) Extract

Ethylhexylglycerin

Fragrance

Glycerin

Hyaluronic Acid

Lauroyl Lysine

Methylheptylglycerin

Musa Sapientum (Banana) Fruit Extract

Niacinamide

Olea Europaea (Olive) Fruit Oil

Polyglyceryl-10 Caprylate/Caprate

Polyurethane-35

Ricinus Communis (Castor) Seed Oil

Saccharomyces Ferment

Sodium Phytate

Sodium Stearate

Sorbitan Olivate

Tapioca Starch

Tocopherol

Tridecane

Trimethylpentanediol/Adipic Acid/Glycerin Crosspolymer

Undecane

Water

Indications and Usage

INDICATIONS & USAGE SECTION

Helps prevent sunburn

If used as directed with other sun protection measures (see Directions), decreases the risk of skin cancer and early skin aging caused by the sun

Keep out of reach of children

OTC - KEEP OUT OF REACH OF CHILDREN SECTION

Keep out of reach of children

In case of ingestion, get medical help or contact a Poison Control Center right away

Purpose

OTC - PURPOSE SECTION

Sunscreen

Vacation Super Stick SPF 45

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

Super Stick SPF 45Super Stick SPF 45

Super Stick SPF 45 backSuper Stick SPF 45 back

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDCProductDescriptionFormQuantityStrengthSPL version
80641-017-87Vacation Super20 g in 1 APPLICATORSTICK201

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDCDashboard titleSPL versionValidationDashboard ZIP
80641-017VACATION SUPER (AVOBENZONE HOMOSALATE OCTISALATE OCTOCRYLENE) STICK [VACATION INC.]1Current NDC, 1 package rows20240314_137c350b-dca1-47f7-e063-6294a90a531e.zip

Products#

Every source-derived product name is available through these pages.

DailyMed product names page 1 of 1 · 7 matching rows.

NDC Codes#

Product NDC, Package NDC table
Product NDCPackage NDC
80641-01780641-017-87

Ingredients#

Every source-derived ingredient row is available through these pages.

DailyMed ingredient rows page 1 of 1 · 5 matching rows.

Name, UNII, Kind table
NameUNIIKind
OCTOCRYLENE5A68WGF6WMACTIB
AVOBENZONEG63QQF2NOXACTIB
HOMOSALATEV06SV4M95SACTIB
OCTISALATE4X49Y0596WACTIB
WATER059QF0KO0RIACT

Source Document#

Source XML

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
Vacation SuperAVOBENZONE HOMOSALATE OCTISALATE OCTOCRYLENEVacation Inc.137c350b-dca1-47f7-e063-6294a90a531e2024-03-12WarningsExact identifier
ndc (package): 80641-017-87
ndc (product): 80641-017
ndc11 (package): 80641001787
spl id: 137c350b-dca2-47f7-e063-6294a90a531e
spl set id: 137c350b-dca1-47f7-e063-6294a90a531e

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.